ResearcherCleveland ClinicActive in the last 2 years

Sayf Al-deen Said

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6015-5667; OpenAlex author ID A5103050714. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2024: 1 paper

Papers 1

Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergoing Perioperative Chemotherapy and Resec… Co-author DOI 10.1177/00031348241241738 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Toms Augustin · 1 shared paper, 2024 · strength 0.21
- Paper Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergo… DOI 10.1177/00031348241241738 ↗
Jenny H. Chang · 1 shared paper, 2024 · strength 0.21
- Paper Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergo… DOI 10.1177/00031348241241738 ↗
Breanna C. Perlmutter · 1 shared paper, 2024 · strength 0.21
- Paper Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergo… DOI 10.1177/00031348241241738 ↗
Richard Matthew Walsh · 1 shared paper, 2024 · strength 0.21
- Paper Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergo… DOI 10.1177/00031348241241738 ↗
Chase J. Wehrle · 1 shared paper, 2024 · strength 0.21
- Paper Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergo… DOI 10.1177/00031348241241738 ↗
Samer A. Naffouje · 1 shared paper, 2024 · strength 0.21
- Paper Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergo… DOI 10.1177/00031348241241738 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.